BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20657289)

  • 21. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neo-adjuvant and adjuvant chemotherapy in locally advanced bladder cancer.
    Sternberg CN
    Acta Urol Belg; 1996 May; 64(2):33-4. PubMed ID: 8701807
    [No Abstract]   [Full Text] [Related]  

  • 23. Platinum-based chemotherapy for bladder cancer.
    Waxman J; Wasan H
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):54-60. PubMed ID: 7992067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of muscle-invasive bladder cancer in the elderly.
    Basso U; Bassi P; Sava T; Monfardini S
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1017-35. PubMed ID: 15606330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Simultaneous chemotherapy/radiotherapy in locally advanced unresectable cancer of the bladder].
    Paule B; Saint F
    Prog Urol; 2001 Feb; 11(1):132-40. PubMed ID: 11296634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined therapy for patients with invasive bladder cancer].
    Startsev VIu; Karelin MI
    Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer.
    Piet AH; Hulshof MC; Pieters BR; Pos FJ; de Reijke TM; Koning CC
    Strahlenther Onkol; 2008 Jun; 184(6):313-8. PubMed ID: 18535807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
    J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of muscle invasive bladder cancer. Is there a role for neoadjuvant chemotherapy?
    Kuten A; Baz M; Rubinov R; Dale J; Haim N; Robinson E; Cohen Y
    Strahlenther Onkol; 1994 Sep; 170(9):524-30. PubMed ID: 7524174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
    Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoscopic operations in invasive cancer of the urinary bladder].
    Martov AG; Chernyshev IV; Sysoev PA; Gushchin BL; Shapovalov VV; Kozlov VV; Kornienko SI
    Urologiia; 2005; (2):35-9. PubMed ID: 15989025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
    Pollack A; Zagars GZ
    Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options and treatment of muscle invasive bladder cancer.
    O'Connor RC; Alsikafi NF; Steinberg GD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ preservation in the management of bladder and prostate cancer.
    Vitale V
    Rays; 1997; 22(3):406-9. PubMed ID: 9446944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.
    Nieuwenhuijzen JA; Pos F; Moonen LM; Hart AA; Horenblas S
    Eur Urol; 2005 Aug; 48(2):239-45. PubMed ID: 16005375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.